Shanghai Futuo Biotech Development Co., Ltd. announced that it expects to receive CNY 200 million in funding from Shanghai Fosun Pharmaceutical Co., Ltd., Shanghai Fosun Health Industry Holding Company Limited
Shanghai Futuo Biotech Development Co., Ltd. announced that it will receive CNY 200,000,000 in an equity round of funding from existing investors Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) and Shanghai Fosun Health Industry Holding Company Limited on January 10, 2018. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) will invest CNY 102,000,000 and Shanghai Fosun Health Industry Holding Company Limited will invest CNY 98,000,000 in the transaction.